Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Per this morning prelim results for Q4, and the discussion re. share buyback, he stated that a special vote of shareholders would be scheduled as quickly as possible in Q2, then and / if approved would proceed quickly for approval required in UK. But then, on the JPM call did I hear correctly that the share buyback might be early 2025? Can anyone substantiate if that is what he said? I'm not certain the 2025 date was tied to the actual BB or something else.
TIA
lizzy241, looks like an approximate 700K share buy just went through Can you see that?
AMRN has over 1M shares traded in PM. Should be an interesting day to find out where this new positive news takes us. It certainly should keep us over the $1. threshold. Should be a scramble for the exits for any remaining shorts. GLTA longs.
It's nice to see some positive news from Amarin. Q4 revenue up over 65% from Q3 and cash positive. The buyback of $50M I brought up a couple of months ago to some posters negative comments. When your cash positive Q/Q, share price is so low and EU and ROW are increasing revs, it should provide a huge boost to shareholder moral and WS. Looks like AD and the board have this moving in a good direction. JMO
ramfan60, depends on what type of dog you have. I have a couple of Aussies and most times I can trust them but not always. :)
Whal, from looking at ATHA, it hit a high a year ago of $4.42 and then fell back and has since November 22 doubled sp due to the P2/3 as you mention. Sitting at $3.16 on today's 10% jump. Any thoughts on probability of success and a sp estimate?
JR, this is what you stated yesterday in one of your cynical posts.
DAR, what exactly will educate doctors? There is zero budget for sales & marketing in the U.S. There is no active education system in place. And that does not appear to be changing anytime soon (if ever).
Honestly, I don't see how this moves the needle, other than maybe some existing gIPE patients switching to branded Vascepa.
Today you are stating 'great stuff', Yes, I would assume docs get updated........Can you explain your seemingly changed postion?
JR, it's Medicare DA. All Medicare enrollees are not low income. Are you serious. Medicaid is a government program for lower income people. And as for your comment that someone else said that, I did not see anything on this board referring to the low income supplement.
JR, why do you always take a negative approach to AMRN. The glass is ALWAYS half empty and pouring like a sieve with you. Your response is that you are only speaking facts. And, why did you state that it's for the low income Medicare patients? It's for any and all of the 65M people enrolled in Medicare that have CVD and are on statins. JMO
cloudera, from my understanding, the revenue per patient is approximately $1,500 annually. (Remember, that is not what a patient pays.) Assuming 2.5M patients, that would represent approximately $3.75B. Now the key is how to get 2.5M patients. We are still in the education of doctors for writing scripts.
I will defer the revenue stream to CaptBeer.
Thx.
DMC8, thanks for posting. This is really good news. There are over 51.5M people on Medicare Part D. 19% would be approximately 10M. Not sure without researching on how many of those 51.5M have issues that require V but found the below information regarding statins.
As Medicare Part D enrollment grew from 37.7 million to 44.3 million beneficiaries during these years, the number of beneficiaries using cholesterol-lowering drugs rose from 20.5 million (54.3%) to 25.2 million (56.9%), which was largely associated with beneficiaries using statins rising from 19.6 million (52.0%) in 2014 to 24.2 million (54.7%) in 2018.
The numbers should be higher today if the 54.3% ration holds and the number of people on Medicare Part D is now up to 51.5M, thus having ~28M people now on statins. Being preferred for 19% of those would yield approximately 5.32M people now having a potential for V.
Let me know if this logic is correct. TIA
JRoon, as I recall, sleven posted that he heard from a reliable source that it had been presented, not that his source had actually seen the presentation at CTAD.
RMB, is the numbers shown reflective of these companies total cost basis of these shares reported as owned?
Capt, thanks, and the same to you. We appreciate all you do for this Amarin board. Prayers for a successful 2024 for AMRN and all the longs. GLTA
DMC8, thanks for the article. I have copied a small portion of the findings from their studies. However this came from a linked article from 2018.
There's a growing body of evidence to suggest most vitamin supplements don't do all that much. In fact, a study earlier this year found how some of the most popular vitamin supplements, including vitamin C and calcium, don't really have major health benefits.
The next pill in the firing line is fish oil. Also known as omega-3, fish oil has been widely publicised as being protective against heart disease, but according to a new Cochrane review, led by the University of East Anglia, the supplements offer little benefit to those taking them.
Omega-3 fats like alphalinolenic acid (ALA), eicosapentaenoic acid, and docosahexaenoic acid, are certainly good for you, because they are essential for our health.
But the review, which combined the results from 79 different trials, involving over 112,000 people, found that omega-3 supplements like fish oils didn't seem to protect the heart.
We need more of this word to get out to the doctors and public.
lizzy241, thanks for that positive article. That puts a target price at around $3.30. We need more positive articles and upgrades. Hopefully the JPM presentation will gain additional positive traction for 2024.
Jas, I understand and agree. I was attempting to fill in some blanks for RMB as his post appeared to have some doubt in the overall Sarissa position.
Thx and GLTA
And BTW, sure hope AD is able to move Amarin to pursue the fraud in the original patent Dusaster.
RMB, Sarissa Capital in total owns 33M+ shares, however as stated previously much of that was moved to various Sarissa companies therefore not reported un Sarissa Capital. These are estimated numbers from memory, but I believe they were showing 9M+ shares and they purchased another ~4M shares which is what you are seeing on your link.
But again, total shares are `33M or 8.2% of Amarin shares.
RMB, thanks for your response. I understand your prior statement and just wanted state my direct experience.
I'm blessed that i don't have any issues that would require me to take V, or for that matter anything but a low level BP med.
I always, enjoy your posts and support for AMRN.
RMB, I have Medicare B through Humana and the Advantage Gold Plus and get my medical and drugs for $164.90 per month. 2024 it is going up to $172. And like someone stated, they do cover V although I do not take it so I don't know the cost.
Number sleven, thanks for the information but after reading a couple of pages of medical jargon, I think I'll stay with Capt Beer's words. It's the EPA Stupid. But I do like tm100's phrase, "It's the Vascepa EPA Stupid".
Cheers for a BRAVE new world.
lizzy241, yes, that is exactly the breakdown of companies i was looking for. Although, it is a little difficult to understand exactly what the various companies ownership actually is, however that is not important. The fact is that AD (Sarrisa) owned the 25,210,000 within these various Sarrisa companies before his most recent purchases. As he stated this week, he has not sold any shares.
lizzy241, thanks. That's what I recalled so I can look back as well.
Thanks again.
lizzy241, do you recall where the information regarding the 7-8 companies that Sarrisa moved some of their original shares purchases to? I have looked but can't recall if it was in something Sarrisa sent out or where they were listed.
Mr Stockboy, and I would be over the top estatic. I do dream of better days. Still a lot of things to occur, but in my opinion, good Brave results would have to be viewed by the market as very positive. Then, EU, ROW, to build revenue to then gain more attention via marketing to docs.
north40000, thanks for the source. So, apparently and based on the Hazel Atlas Glass v. Hartford,
'Even if Hazel failed to exercise due diligence to uncover the fraud, relief may not be denied on that ground alone, since public interests are involved. P. 322 U. S. 246.' Justice Black stated this in his opinion.. This case involves the power of a Circuit Court of Appeals, upon proof that fraud was perpetrated on it by a successful litigant, to vacate its own judgment entered at a prior term and direct vacation of a District Court's decree entered pursuant to the Circuit Court of Appeals' . Time is not necessarily a factor since the HAG v Hartford covered many years.
I'm not an attorney but the way I read this is that your referenced case above provides the precedent to go back to the court on the basis of fraud. We have comments on both sides of this on this board, but as I recall, the Federal Court of Appeals (Dyk and Reyna) said no standing when Marjac presented, and when the attempt to get it before the Supreme Court, like most cases, they would not hear it. So 'fraud' is still an option to pursue. If this is correct, then it baffles me as to why Amarin has not done anything with this.
I defer to your legal response instead of the many others that have their opinions.
Thanks again.
Zip, and I'm sure that Michael (Marjac) would do anything to assist, but is there not a deadline for any recourse? Please tell me there is not and that Amarin could take that back up in an appeal.
zip, I am not a legal expert by any means, but I thought we had exhausted our chances of getting Judge Du's disasterous decision overturned with the two appeals that Marjac attempted. (which we all know he was brilliant in his attempt) Is there actually a pathway in which we can go back with a 'fraud upon the court' case? I know the second shot Marjac took was ruled out as not having standing. And Dyk and Reyna had their minds made before the case began. Sorry POS's.
TIA
13D/A shows that Sarrisa Capital picked up an additional 4,170,000 shares thus taking their total shares to 33,470,000. Hopefully the market will take that as a positive today and get us a higher price. GLTA
Denisk, Sarrisa reported owning 29,300,000 AMRN in September. Tomorrow morning will be interesting to how many more they have purchased. I guess it has to be more than 4M shares to trigger the 1% change in ownership.
JRoon, I just wish we would see another 13F with another sizable purchase. That would make for some badly needed good news.
Monk44, I am with you as are Many Others. It can't happen soon enough, but I expect we have at least another 12-18 months.
Going back to an earlier discussion this week regarding shares owned by Sarrisa Capital I found the info copied below.
13D/G Filings
We present 13D/G filings separately from the 13F filings because of the different treatement by the SEC. 13D/G filings can be filed by groups of investors (with one leading), whereas 13F filings cannot.
More than one site show Sarrisa Capital having 29,300,000 shares. If you look at strictly the 13F from September 'Sarrisa Capital' shows 10,440,000 shares which included the last purchase of 4M+ shares. These 10M shares are owned at an average cost of $2.53. The original 24M+ was purchased at a cost over $4.
So is the benefit by moving the shares, that SC gets a huge tax loss going forward and the various 'group of investors' have a much lower cost basis?
still looking for why AD wants to manipulate the sp at these low levels as some have suggested.
TIA for any information and GLTA longs.
JRoon, thanks for the details. I was recalling the emails or Sarrisa statements from earlier this year showing the various companies and their ownership. I didn't ha e time to look and now running to the golf course. Thanks again for the clarification.
JRoon71, I thought the reporting has nothing to do with the value of the shares, but strictly the % of ownership. The 6% ownership triggers the SEC reporting for purchases and / or sales. He originally purchased the ~ 24M shares at a value of over $100M. However, we all know at todays sp, those same shares would be worth $20M. Under his what we believe to be ~10M shares under the Sarissa LLC, that would be ~ 10M / 400M or roughly 4% ownership with the other 20M scattered across the other companies he is associated with.
Jas, as I recall, Sarrisa had 'sold'?/ moved' roughly 20M or their original 24M shares under some other Sarrisa companies. Then 2-3 months ago they purchased ~6M shares under Sarrisa thus giving them ~10,000,000. But as they have stated previously they have not materially sold any shares. Therefore I believe they actually have approximately 30M shares.
NS, thanks. Always enjoy reading your informative posts. And you are correct in the statement that the decisions were appropriate at the time. I am just frustrated by the string of decisions and bad set of circumstances surrounding this stock which I am heavily invested in.
Sleven, I hope they are right this time. Unfortunately didn't work out well for US or Germany. A lot of money lost on those 'premature' moves.
lizzy241, kinda reminds me of another stock that did a 10X on a positive announcement. Unfortunately one is down approximately 97% since that day. ;>(
lizzy241, looks like there are approximately 18M total outstanding CDIO shares that traded back and forth yesterday for 138,466M total. Is this correct?